Last reviewed · How we verify
1.5g Naltrexone Implant
1.5g Naltrexone Implant is a Small molecule drug developed by Shenzhen Sciencare Medical Industries Co., Ltd.. It is currently in Phase 2 development.
At a glance
| Generic name | 1.5g Naltrexone Implant |
|---|---|
| Sponsor | Shenzhen Sciencare Medical Industries Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Randomized, Double-Blind, Single-Center Clinical Study on the Efficacy of Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone (PHASE2)
- Exploring the PK of Different Doses of Naltrexone in Patients With AUD (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 1.5g Naltrexone Implant CI brief — competitive landscape report
- 1.5g Naltrexone Implant updates RSS · CI watch RSS
- Shenzhen Sciencare Medical Industries Co., Ltd. portfolio CI
Frequently asked questions about 1.5g Naltrexone Implant
What is 1.5g Naltrexone Implant?
1.5g Naltrexone Implant is a Small molecule drug developed by Shenzhen Sciencare Medical Industries Co., Ltd..
Who makes 1.5g Naltrexone Implant?
1.5g Naltrexone Implant is developed by Shenzhen Sciencare Medical Industries Co., Ltd. (see full Shenzhen Sciencare Medical Industries Co., Ltd. pipeline at /company/shenzhen-sciencare-medical-industries-co-ltd).
What development phase is 1.5g Naltrexone Implant in?
1.5g Naltrexone Implant is in Phase 2.